Skip to content

Abvc Biopharma, Inc.

ABVC· NasdaqCore metricsCIK 1173313

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -2.42%
Market cap
$26.17M
26.98M shares
Filings
803
$296.00K
FY 2025−41.9% FY25 yoy
$1.15M
Q3 2026N/M FY25 yoy
-$1.24M
Q3 2026N/M FY25 yoy
-$8.54M
Q2 2026derivedN/M FY23 yoy
$0.04
Q3 2026N/M FY25 yoy
$11.29K
Q3 2026+174.4% FY25 yoy
$26.17M
—
88.4×
2.0×
—
—

FY2025 figures · derived

Price

$0.9766.32%$1.91past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$296.00KFY 2025
$50.00M0FY 2013FY 2020FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$296,000reported
FY 20242024-12-31$509,589 revisedreported
FY 20232023-12-31$152,430reported
FY 20222022-12-31$969,783reported
FY 20212021-12-31$355,797reported
FY 20202020-12-31$483,045reported
FY 20192019-12-31$701,719reported
FY 20182018-12-31$6,956reported
FY 20152015-12-31$50,000,000reported
FY 20142014-09-18$0reported
FY 20132013-09-30$7,787reported

Segments

Geography
Long-lived assets by Geography, FY2025 to FY2025FY2025In Taiwan · FY2025 · $8.10MIn USA · FY2025 · $4.74M
LineFY2025ShareChange
In Taiwan$8.10M63%—
In USA$4.74M37%—
Total$12.84M

From the 10-Q filed May 18, 2026ABVC

Pharmaceutical preparations

Abvc Biopharma, Inc. is the 235th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Abvc Biopharma, Inc. · CIK 1173313 · Engraved from SEC EDGAR